GPL has entered into an agreement to become a partner in ABCD Technologies LLP General Announcement Filing viewer · member access Original SGX announcement
Glenmarks Ryaltris nasal spray approved in Europe for treatment of allergic rhinitis General Announcement Filing viewer · member access Original SGX announcement
Tender Offer & Consent Solicitation-2percent.Resettable Onward Starting Eq-linked Securities due2022 General Announcement Filing viewer · member access Original SGX announcement
Proposed IPO of Glenmark Life Sciences Limited Filing of draft red herring prospectus General Announcement Filing viewer · member access Original SGX announcement
Tender Offer & Consent Solicitation 2 per Resettable Onward Starting Securities due2022 General Announcement Filing viewer · member access Original SGX announcement
Announcement of the Results of the Offer General Announcement Filing viewer · member access Original SGX announcement
Tender Offer & Consent Solicitation-2 percent.Resettable Onward Starting Equity-linked Securities General Announcement Filing viewer · member access Original SGX announcement
Tender Offer & Consent Solicitation General Announcement Filing viewer · member access Original SGX announcement
Glenmark receives India Pharma Innovation of the Year Award from the Govt of India General Announcement Filing viewer · member access Original SGX announcement
Glenmark s Ryaltris innovative single nasal spray, ready to market in Russia General Announcement Filing viewer · member access Original SGX announcement
Glenmark launches SUTIB (Sunitinib) priced lower than the innovator brand General Announcement Filing viewer · member access Original SGX announcement
Outcome of the Board Meeting to consider repurchase of Foreign Currency Debt General Announcement Filing viewer · member access Original SGX announcement
Third Quarter Results Financial Statements and Related Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate Gel General Announcement Filing viewer · member access Original SGX announcement
Intimation of Board Meeting to consider repurchase of Foreign Currency Debt General Announcement Filing viewer · member access Original SGX announcement
Board Meeting Intimation General Announcement Filing viewer · member access Original SGX announcement
Glenmark receives approval for Tadalafil Tablets,Gabapentin Enacarbil Tablets and Apremilast Tablets General Announcement Filing viewer · member access Original SGX announcement
Glenmark and Menarini enter into Exclusive Licensing Agreement for commercializing Ryaltris General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA tentative approval for Axitinib Tablets, 1 mg and 5 mg General Announcement Filing viewer · member access Original SGX announcement
Glenmark secures its position in the prestigious Dow Jones Sustainability Emerging Markets Index General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for Tacrolimus Capsules General Announcement Filing viewer · member access Original SGX announcement
Unaudited Financial Results for the Second Quarter and Half Year ended September 30, 2020 General Announcement Filing viewer · member access Original SGX announcement
Information under Regulation 30 of SEBI (LODR) Regulations General Announcement Filing viewer · member access Original SGX announcement